Biohaven (BHVN) Other Non Operating Income (2021 - 2024)
Biohaven's (BHVN) quarterly Other Non Operating Income came in at $4.3 million in Q1 2024, down 47.69% year-on-year from $8.2 million in Q2 2023, and down 44.4% quarter-over-quarter from $7.7 million in Q4 2023.
Biohaven (BHVN) Other Non Operating Income (2021 - 2024) Analysis & Trends
Biohaven has disclosed Other Non Operating Income across 4 years of filings, most recently posting $4.3 million for Q1 2024.
- Other Non Operating Income for Q1 2024 came in at $4.3 million, down 47.69% year-over-year; the trailing twelve-month figure through Mar 2024 was $22.6 million (up 256.99% YoY), and the FY2025 annual result was $8.0 million, down 79.71% from the prior year.
- Other Non Operating Income came in at $4.3 million for Q1 2024 at Biohaven, down from $7.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $8.2 million in Q1 2023 to a low of -$1.8 million in Q4 2022.
- The 4-year median for Other Non Operating Income is $2.9 million (2021), against an average of $3.0 million.
- Across the five-year window, Other Non Operating Income sank 226.41% in 2022 and soared 205825.0% in 2023, its largest moves.
- Biohaven's Other Non Operating Income stood at $1.5 million in 2021, then tumbled by 226.41% to -$1.8 million in 2022, then soared by 521.27% to $7.7 million in 2023, then sank by 44.4% to $4.3 million in 2024.
- The last three Other Non Operating Income figures came in at $4.3 million (Q1 2024), $7.7 million (Q4 2023), and $4.7 million (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 5.84 Mn |
| Mar 31, 2023 | 8.23 Mn |
| Dec 31, 2022 | -1.84 Mn |
| Jun 30, 2022 | -67,000.00 |
| Mar 31, 2022 | -4,000.00 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | -5,000.00 |